@article{35e935b6c9c44edb9af3b9cd458286db,
title = "mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?",
keywords = "2019-nCoV Vaccine mRNA-1273, Antibodies, Viral, BNT162 Vaccine, COVID-19 Vaccines, Humans, Kidney Transplantation, Renal Dialysis, Transplant Recipients",
author = "Wijtvliet, \{Veerle P W M\} and Ari{\"e}n, \{Kevin K\} and Steven Abrams and Couttenye, \{Marie M\} and Fabienne Mestrez and Joachim Mari{\"e}n and \{De Winter\}, \{Benedicte Y\} and \{Van Damme\}, Pierre and Lissa Pipeleers and Wissing, \{Karl Martin\} and Daniel Abramowicz and Ledeganck, \{Kristien J\}",
note = "FTX",
year = "2022",
doi = "10.1093/ndt/gfab352",
language = "English",
volume = "37",
pages = "799--803",
journal = "Nephrology, Dialysis, Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "4",
}